Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
00874 BAIYUNSHAN PH
RTNominal up19.040 +0.040 (+0.211%)
Result Announcements

19/08/2021 15:56

Baiyunshan Ph (00874) interim net up 42% to RMB2.5 billion

[ET Net News Agency, 19 August 2021] Guangzhou Baiyunshan Pharmaceutical Holdings
Company Limited (00874) said its net profit attributable to the shareholders of the
company was RMB2.5 billion for the six months ended 30 June 2021, a year-on-year increase
of 41.84%. No dividend will be distributed.
Income from operations was RMB36.13 billion, a year-on-year increase of 18.57%. (RC)

Remark: Real time quote last updated: 01/12/2021 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2021 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.